ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,928Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 617

$483K Total Retail Price of All Prescriptions

Rank: 111 out of 617

489 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 489 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 489 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,678 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 452 328 1 3
LEVOTHYROXINE SODIUM 398 370 2 1
LISINOPRIL 392 340 3 5
FUROSEMIDE 367 301 4 4
TRAMADOL HCL 316 196 5 15
SIMVASTATIN 247 209 6 2
AMLODIPINE BESYLATE 232 210 7 6
CITALOPRAM HBR 201 164 8 18
POTASSIUM CHLORIDE 170 125 9 10
WARFARIN SODIUM 169 114 10 7
HYDROCODONE-ACETAMINOPHEN 167 122 S3 11 8
GABAPENTIN 166 131 12 16
LOSARTAN POTASSIUM 155 151 13 22
METOPROLOL SUCCINATE 154 141 14 12
TRAZODONE HCL 144 120 15 51
SERTRALINE HCL 136 96 16 20
METOPROLOL TARTRATE 135 123 17 11
METFORMIN HCL 134 89 18 9
RANITIDINE HCL 125 75 19 40
ALLOPURINOL 119 119 20 27
ENALAPRIL MALEATE 110 92 21 34
HYDROCHLOROTHIAZIDE 109 97 22 13
GLIMEPIRIDE 106 81 23 33
MELOXICAM 101 88 24 24
ZOLPIDEM TARTRATE 101 58 24 23
SPIRONOLACTONE 99 82 26 42
TAMSULOSIN HCL 97 86 27 26
ATENOLOL 97 81 27 17
NEXIUM 97 69 27 43
PRAVASTATIN SODIUM 88 85 30 21
CEPHALEXIN 86 67 31 68
PREDNISONE 85 76 32 31
ISOSORBIDE MONONITRATE ER 80 80 33 52
ATORVASTATIN CALCIUM 79 67 34 14
ROPINIROLE HCL 75 50 35 66
FLUTICASONE PROPIONATE 74 50 36 36
MIRTAZAPINE 70 70 37 50
DONEPEZIL HCL 69 69 38 30
LYRICA 69 54 38 92
OXYCODONE HCL 66 49 S2 40 130
CYMBALTA 66 52 40 49
TRIAMTERENE-HCTZ 65 61 42 47
OXYBUTYNIN CHLORIDE ER 64 61 43 114
CARVEDILOL 63 52 44 19
LANTUS 63 55 44 39
ZETIA 58 58 46 77
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 46 46 29
CLOPIDOGREL 57 44 48 53
ADVAIR DISKUS 56 45 49 38
DIOVAN 56 56 49 41
METFORMIN HCL ER 54 40 51 72
SPIRIVA 54 47 51 61
CRESTOR 53 43 53 28
PANTOPRAZOLE SODIUM 52 48 54 37
QUETIAPINE FUMARATE 50 30 55 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.